Randomized, Double-blind, Sham-controlled Trial to Investigate Combined

See also
Status	Clinical Trial	Phase
Completed	`NCT05720819` - Biofeedback-VR for Treatment of Chronic Migraine	N/A
Not yet recruiting	`NCT06428838` - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context	Phase 3
Recruiting	`NCT05517200` - Pilot Study for a Machine Learning Test for Migraine
Recruiting	`NCT05891808` - miR-155 Expression in Episodic and Chronic Migraine
Completed	`NCT02514148` - Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients	N/A
Enrolling by invitation	`NCT02291380` - A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine	Phase 3
Withdrawn	`NCT02122744` - RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine	N/A
Completed	`NCT02122237` - Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial	Phase 3
Recruiting	`NCT02202486` - Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI	N/A
Completed	`NCT01709708` - Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine	Phase 4
Completed	`NCT01741246` - Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging	N/A
Completed	`NCT01090050` - Treximet in the Treatment of Chronic Migraine	Phase 4
Recruiting	`NCT03507400` - Introvision for Migraine and Headaches	N/A
Completed	`NCT04161807` - Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine	N/A
Completed	`NCT03175263` - OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain	N/A
Withdrawn	`NCT04353505` - Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache	Phase 1
Completed	`NCT01667250` - Non-Invasive Neurostimulation for the Prevention of Chronic Migraine	N/A
Completed	`NCT01700387` - A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency	Phase 4
Not yet recruiting	`NCT01135784` - Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache	Phase 2
Completed	`NCT00772031` - NINDS CRC Chronic Migraine Treatment Trial	Phase 3

NCT number	NCT06450444
Study type	Interventional
Source	Salvia BioElectronics
Contact
Status	Not yet recruiting
Phase	N/A
Start date	June 24, 2024
Completion date	February 1, 2027

Randomized, Double-blind, Sham-controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. — RECLAIM

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms